Summary

11.30 0.04(0.31%)09/13/2024
Inogen Inc (INGN)

Key Facts


1 Day1 Week1 Month3 Months6 Months1 Year5 YearsAll Time
0.310.36-9.5343.4058.0495.16-76.66-25.41


Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1


Trading Data
Close11.30
Open11.45
High11.55
Low11.25
Volume197,142
Change0.04
Change %0.31
Avg Volume (20 Days)124,626
Volume/Avg Volume (20 Days) Ratio1.58
52 Week Range4.13 - 13.33
Price vs 52 Week High-15.23%
Price vs 52 Week Low173.61%
Range-1.31
Gap Up/Down-0.23
Fundamentals
Market Capitalization (Mln)269
EBIDTA-40,414,000
PE Ratio0.0000
PEG Ratio3.4800
WallStreet Target Price7.00
Book Value8.1500
Earnings Per Share-4.1600
EPS Estimate Current Quarter-0.7600
EPS Estimate Next Quarter-0.6000
EPS Estimate Current Year-2.2100
EPS Estimate Next Year-1.9300
Diluted EPS (TTM)-4.1600
Revenues
Profit Marging-0.3007
Operating Marging (TTM)-0.1982
Return on asset (TTM)-0.1065
Return on equity (TTM)-0.4086
Revenue TTM321,523,008
Revenue per share TTM13.8150
Quarterly Revenue Growth (YOY)0.0810
Quarterly Earnings Growth (YOY)0.8730
Gross Profit (TTM)153,533,000
Dividends
Dividend Share0.0000
Dividend Yield
Valuations
Trailing PE0.0000
Forward PE0.0000
Price Sales (TTM)0.0000
Price Book (MRQ)0.8383
Revenue Enterprise Value 0.2064
EBITDA Enterprise Value-1.1165
Shares
Shares Outstanding23,546,900
Shares Float19,947,885
Shares Short0
Shares Short (Prior Month)0
Shares Ratio0.00
Short Outstanding (%)0.00
Short Float (%)0.08
Insider (%)1.28
Institutions (%)98.75


08/22 14:20 EST - zacks.com
Inogen (INGN) Rises 127% Year to Date: What's Driving the Stock?
Expanding product portfolio and high prospects for POC raise optimism for the Inogen (INGN) stock.
08/08 13:01 EST - zacks.com
Inogen (INGN) Reports Q2 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Inogen (INGN) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
08/07 12:36 EST - zacks.com
Inogen (INGN) Q2 Earnings Beat Estimates, Revenues Rise Y/Y
Inogen's (INGN) second-quarter 2024 results reflect significant improvement in the top and bottom lines, driven by strong international and domestic business-to-business sales.
08/06 21:11 EST - seekingalpha.com
Inogen, Inc. (INGN) Q2 2024 Earnings Call Transcript
Inogen, Inc. (NASDAQ:INGN ) Q2 2024 Earnings Conference Call August 6, 2024 5:00 PM ET Company Participants Ryan Peterson - IR Kevin Smith - President and CEO Mike Bourque - CFO Conference Call Participants Lilia-Celine Lozada - JPMorgan James Beer - William Blair Colin Clark - Stifel Michael Matson - Needham & Company Operator Welcome to Inogen's Second Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, August 6, 2024.
08/06 19:05 EST - zacks.com
Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates
Inogen (INGN) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to loss of $0.42 per share a year ago.
07/22 06:24 EST - investorplace.com
3 Stocks Under $10 With the Potential for Massive Gains
Investing in small-cap stocks can be a gateway to high returns, mainly when these companies exhibit strong growth fundamentals and strategic market positioning. Here, the focus is on three stocks to buy under $10.
07/15 10:02 EST - zacks.com
3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio Now
Expanding product portfolio and high prospects for POC raise optimism for Inogen (INGN) stock.
07/03 16:10 EST - businesswire.com
Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Kevin P. Smith as General Counsel and Executive Vice President, Business Development, effective July 22, 2024. Mr. Smith joins Inogen from Sirtex Medical, where he served as General Counsel and Executive Vice President, Business Development, since 2018. Mr. Smith brings nearly thirty years of exper.
06/03 16:05 EST - businesswire.com
Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio
GOLETA, Calif.--(BUSINESS WIRE)--Inogen Announces Publication of Study.
05/20 11:45 EST - https://www.accesswire.com
Antea Group UK Joins Inogen Alliance
NORTHAMPTON, MA / ACCESSWIRE / May 20, 2024 / Inogen AllianceInogen Alliance is pleased to announce the addition of a new Associate company, Antea Group UK. The addition of this new Associate allows us to continue to provide strong EHS and Sustainability support with needed coverage in the United Kingdom. This is a new branch of Antea Group companies which already have multiple Associates across the USA, Brazil, France, Belgium and the Netherlands. In choosing new Associate companies to join the Alliance we have a thorough due diligence process to ensure alignment in values, services and complimentary coverage with our existing companies and approval by the Board of Directors.Antea Group is an international engineering and environmental consulting firm. They specialize in full-service solutions in the fields of environment, health & safety, and sustainability. By combining strategic thinking, multidisciplinary perspectives and technical expertise, they deliver sustainable results for a better future. At Antea Group, subject matter experts are also skilled advisors who fully invest in understanding business drivers and unique culture. Key services include EHS compliance and assurance, environmental due diligence & transactional ESG, corporate mergers & acquisitions, water management, regulatory compliance, EHS management systems, risk management, environmental, contaminated land &geotechnical services, and ecology & arboriculture."We are excited to officially join Inogen Alliance to continue to expand and enhance the global coverage we offer the marketplace. Many of Antea Group UK's clients are multinational and being part of the Alliance allows us to support them with global coverage and local expertise. Having associates around the world who understand the local regulations, their intent and how they may or may not apply to UK client operations is a key differentiator for the firm" Keith Knoke, interim COO, Antea Group UK.More information on Antea Group UK is available here.Inogen Alliance is a global network made up of dozens of independent local businesses and over 6,000 consultants around the world who can help make your project a success. Our Associates collaborate closely to serve multinational corporations, government agencies, and nonprofit organizations, and we share knowledge and industry experience to provide the highest quality service to our clients. If you want to learn more about how you can work with Inogen Alliance, you can explore our Associates or Contact Us. Watch for more News & Blog updates here and follow us on LinkedIn.View additional multimedia and more ESG storytelling from Inogen Alliance on 3blmedia.com.Contact Info:Spokesperson: Inogen AllianceWebsite: https://www.3blmedia.com/profiles/inogen-allianceEmail: info@3blmedia.comSOURCE: Inogen Alliance
05/09 14:32 EST - zacks.com
Inogen (INGN) Q1 Earnings Top Estimates, Revenues Up Y/Y
Higher business-to-business sales aid Inogen's (INGN) overall first-quarter results.
05/07 22:30 EST - seekingalpha.com
Inogen, Inc. (INGN) Q1 2024 Earnings Call Transcript
Inogen, Inc. (NASDAQ:INGN ) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Ryan Peterson - Investor Relations Kevin Smith - President and Chief Executive Officer Mike Bourque - Chief Financial Officer Conference Call Participants Colin Clark - Stifel Margaret Kaczor - William Blair Mike Matson - Needham & Company Operator Welcome to Inogen's First Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode.
05/07 21:01 EST - zacks.com
Here's What Key Metrics Tell Us About Inogen (INGN) Q1 Earnings
While the top- and bottom-line numbers for Inogen (INGN) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
05/07 16:05 EST - businesswire.com
Inogen Announces First Quarter 2024 Financial Results
GOLETA, Calif.--(BUSINESS WIRE)--Inogen Announces First Quarter 2024 Financial Results.
04/10 08:30 EST - businesswire.com
Inogen to Report First Quarter 2024 Financial Results on May 7, 2024
GOLETA, Calif.--(BUSINESS WIRE)--Inogen to Report First Quarter 2024 Financial Results on May 7, 2024.
03/28 12:36 EST - zacks.com
Inogen (INGN) Up 26.6% Since Last Earnings Report: Can It Continue?
Inogen (INGN) reported earnings 30 days ago. What's next for the stock?
03/28 12:31 EST - zacks.com
3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio
Expanding product portfolio and high prospects for POC raise optimism for Inogen (INGN) stock.
03/25 08:30 EST - businesswire.com
Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference
GOLETA, Calif.--(BUSINESS WIRE)--Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference.
03/07 16:00 EST - businesswire.com
Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that, effective March 4, 2024, the Compensation Committee of Inogen's Board of Directors approved awards of restricted stock units as material inducement to Michael Bourque entering into employment with the company to serve as its Executive Vice President, Chief Financial Officer and Treasurer. The equity awards were.
02/28 10:26 EST - zacks.com
Inogen (INGN) Q4 Earnings Miss Estimates, Gross Margin Improves
Inogen's (INGN) fourth-quarter earnings and revenues miss their respective consensus estimate. Gross margin expands while the company continues to incur losses at the operating level.